Summary
Latest filing:
James P. Quinlan is Chief Financial Officer of Medicus Pharma Ltd. (MDCX). 2 SEC Form 4 filings on record, most recently on 13 August 2025.
Recent Transactions
2Every recent SEC Form 4 transaction James P. Quinlan has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at James P. Quinlan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Catalyst4, Inc. - $191.21M of MPLT open-market activity in the last 12 months
- John Oyler - $189.61M of ONC open-market activity in the last 12 months
- Michael Benkowitz - $174.13M of UTHR open-market activity in the last 12 months
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M of KYMR open-market activity in the last 12 months
- Keith S. Manchester - $154.47M of ROIV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James P. Quinlan?
James P. Quinlan is a corporate insider, tracked as Chief Financial Officer of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did James P. Quinlan last file a Form 4?
The most recent primary Form 4 on record is dated 13 August 2025, one of 2 filings going back to 2025.
Where can I see all of James P. Quinlan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James P. Quinlan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
